{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T11:36:23Z","timestamp":1699961783642},"reference-count":9,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1157\/13111714","type":"journal-article","created":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T17:15:15Z","timestamp":1194628515000},"page":"597","source":"Crossref","is-referenced-by-count":1,"title":["Ginecomastia y dutasterida"],"prefix":"10.1016","volume":"129","author":[{"given":"Diego","family":"Barral Tafalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Maluf Salad\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n","family":"Kreis Esmendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mag\u00ed","family":"Farr\u00e9 Albaladejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13111714_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0025-7753(07)72563-0","article-title":"Ginecomastia por dutasterida","volume":"128","author":"Fern\u00e1ndez","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13111714_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1464-410X.2005.05909.x","article-title":"Long-term therapy with the dual 5alpha-reductase inhibitor dutasteride is well tolerated in men with symptomatic benign prostatic hyperplasia","volume":"97","author":"Schulman","year":"2006","journal-title":"BJU Int"},{"key":"10.1157\/13111714_bib3","first-page":"203","article-title":"Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase","volume":"7","author":"Marihart","year":"2005","journal-title":"Rev Urol"},{"key":"10.1157\/13111714_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14656566.6.2.311","article-title":"Dutasteride: a novel dual inhibitor of 5alpha-reductase for benign prostatic hyperplasia","volume":"6","author":"Djavan","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1157\/13111714_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.urology.2004.01.001","article-title":"Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia","volume":"63","author":"Roehrborn","year":"2004","journal-title":"Urology"},{"key":"10.1157\/13111714_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2004.05.008","article-title":"ARIA3001, ARIA3002 and ARIB3003 Study Investigators Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia","volume":"46","author":"Debruyne","year":"2004","journal-title":"Eur Urol"},{"key":"10.1157\/13111714_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2165\/00002512-200320120-00005","article-title":"Dutasteride","volume":"20","author":"Evans","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1157\/13111714_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0302-2838(03)00198-2","article-title":"Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia","volume":"44","author":"Andriole","year":"2003","journal-title":"Eur Urol"},{"key":"10.1157\/13111714_bib9","first-page":"335","article-title":"El sistema espa\u00f1ol de farmacovigilancia","volume":"103","author":"Laporte","year":"1994","journal-title":"Med Clin (Barc)"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307729263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307729263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T02:21:23Z","timestamp":1546482083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775307729263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":9,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0025775307729263"],"URL":"https:\/\/doi.org\/10.1157\/13111714","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}